Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Category Archives: Predictive Oncology Inc. POAI

MissionIRNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Executes Repayments, Extensions of Promissory Notes

Posted on October 1, 2019 by MissionIR

Predictive Oncology (NASDAQ: POAI) on Monday announced that it repaid or extended the secured promissory notes that were due September 28, 2019. POAI repaid the remaining principal and interest balance of $478,590 on one note on September 27th. The company … Continue reading →

Posted in MissionIRNewsBreaks, Predictive Oncology Inc. POAI | Leave a comment

MissionIRNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Bringing Precision Medicine Tools to Physicians

Posted on September 27, 2019 by MissionIR

Predictive Oncology (NASDAQ: POAI) is assisting clinicians and researchers in improving outcomes for cancer patients via its AI-driven, tumor-profiling platform. A recent article discussing the company reads, “POAI’s technology combines its database of evidence documenting actual drug responses of cancer … Continue reading →

Posted in MissionIRNewsBreaks, Predictive Oncology Inc. POAI | Leave a comment

MissionIRNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Transforming Cancer-Treatment Outcomes via Proprietary Database

Posted on September 20, 2019 by MissionIR

Predictive Oncology (NASDAQ: POAI) is taking a unique approach to cancer treatment by utilizing its proprietary database of cancer cases using the proven power of artificial intelligence (“AI”). A recent article discussing the company reads, “The company works alongside pharmaceutical, … Continue reading →

Posted in MissionIRNewsBreaks, Predictive Oncology Inc. POAI | Leave a comment

Predictive Oncology Inc. (NASDAQ: POAI) Uses Smart Tumor Profiling Platform with AI to Bring Value to Pharmaceutical, Biotech Industries

Posted on September 19, 2019 by MissionIR

POAI’s artificial intelligence (AI)-driven tumor profiling platform brings precision medicine tools to clinicians and researchers to improve cancer outcomes The company holds a critical strategic advantage over mammoth competitors, attracting investor attention POAI is committed to providing sophisticated tools to … Continue reading →

Posted in Predictive Oncology Inc. POAI | Leave a comment

Predictive Oncology Inc. (NASDAQ: POAI) Utilizes Proprietary Dataset to Revolutionize Treatment Outcomes for Cancer

Posted on September 18, 2019 by MissionIR

Predictive Oncology is working to develop highly customizable assessment methods to individualize treatment options for cancer, improving outcomes POAI’s innovative technology is pioneering in the field of individualizing treatment for ovarian cancer Predictive Oncology offers potential for significant ROI as … Continue reading →

Posted in Predictive Oncology Inc. POAI | Leave a comment

MissionIRNewsBreaks – Why Predictive Oncology Inc. (NASDAQ: POAI) Is ‘One to Watch’

Posted on September 6, 2019 by MissionIR

Data and artificial intelligence-driven discovery services company Predictive Oncology (NASDAQ: POAI) provides predictive models of tumor drug response to improve patient outcome. A recent article discussing the company reads, “Helomics applies artificial intelligence to its rich data gathered from patient … Continue reading →

Posted in MissionIRNewsBreaks, Predictive Oncology Inc. POAI | Leave a comment

Predictive Oncology Inc. (NASDAQ: POAI) is “One to Watch”

Posted on September 3, 2019 by MissionIR

Helomics is collaborating with the University of Pittsburgh School of Medicine to study the use of artificial intelligence to improve clinical decision making for ovarian cancer patients. More than 22,000 women are diagnosed with ovarian cancer in the U.S. each … Continue reading →

Posted in Predictive Oncology Inc. POAI | Leave a comment